Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
Elanco Animal Health announced the U.S. Food and Drug Administration (FDA) approved Bexacat™ (bexagliflozin tablets), the first orally administered prescription medication to improve glycemic control in cats with diabetes mellitus.
read more
The gummy vitamins market is driven by the rise in digital media marketing and social media and augmented through new techniques in flavoring and manufacturing, according to a report by The Business Research Company.
read more
The global empty gelatin capsule market is anticipated to grow at 8.1% between now and 2028, according to a report from Research & Markets. The major factor for the growth of the market is the increasing prevalence of chronic diseases such as CVD, cancer, diabetes, and gastrointestinal diseases coupled with the rising demand for gelatin capsules.
...
read more
The global weight loss supplements market is expected to grow from $30.12 billion in 2021 to $34.19 billion in 2022 at a compound annual growth rate (CAGR) of 13.51%, according to a report by Research & Markets. The weight loss supplements market is expected to grow to $55.41 billion in 2026 at a compound annual growth rate (CAGR) of 12.83%.
read more
The global tablet coatings industry generated $2.2B in 2021, and is anticipated to generate $4.1B by 2031, witnessing a CAGR of 6.6% from 2022 to 2031, according to a report by Allied Market Research.
read more
Hovione and GEA announced a collaboration to advance continuous tableting. This partnership stemmed from a successful customer-supplier relationship spanning several years.
read more
The global animal drug compounding market is estimated to register a CAGR of 7.4% over the forecast period of 2022 to 2031, according to a report by Transparency Market Research.
read more
Mirati Therapeutics, an oncology company, announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval forKRAZATI™ (adagrasib), a targeted treatment option for adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved test, who have ...
read more
The global anti-radiation drug market was valued at $3.4B in 2021 and is anticipated to grow at a CAGR of 9.9% from 2022 to 2031, according to a study by Transparency Market Research.
read more
Yaral Pharma, the US generics subsidiary of IBSA, a multinational pharmaceutical company headquartered in Lugano, Switzerland, launched in the U.S.
read more
The global market for smoking cessation and nicotine de-addiction products is expected to grow at a CAGR of 15% during the forecast period of 2022 to 2030, according to a report from Research & Markets.
read more
The global toxoplasmosis treatment industry generated $683.1M in 2021, and is anticipated to generate $1.09B by 2031, witnessing a CAGR of 4.8% from 2022 to 2031, according to a report from Allied Market Research.
read more
Elanco Animal Health announced the U.S. Food and Drug Administration (FDA) approved Bexacat™ (bexagliflozin tablets), the first orally administered prescription medication to improve glycemic control in cats with diabetes mellitus.
read more
SK Biopharmaceuticals, a global pharmaceutical company, announced that its European partner Angelini Pharma, part of the privately held Italian Angelini Industries, has launched cenobamate in France.
read more
The empty capsules market was valued at $2B in 2020 and is expected to grow at a CAGR of around 8% from 2022-2028, according to a report by UnivDatos Markets Insights,
read more